
ENDRA Life Sciences NDRA
$ 4.34
-1.74%
Quarterly report 2026-Q1
added 05-15-2026
ENDRA Life Sciences P/B Ratio 2011-2026 | NDRA
Annual P/B Ratio ENDRA Life Sciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.62 | 0.324 | 0.000608 | 1.61 | 0.0844 | 5.09 | 2.36 | 1.57 | 1.78 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.09 | 0.000608 | 1.6 |
P/B Ratio of other stocks in the Diagnostics research industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
0.00103 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
1.47 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
2 | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.44 | $ 203.86 | -0.31 % | $ 22.6 B | ||
|
Celcuity
CELC
|
53.4 | $ 88.56 | -4.35 % | $ 4.14 B | ||
|
Akumin
AKU
|
0.532 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
0.284 | $ 4.22 | -6.22 % | $ 5.61 M | ||
|
Fulgent Genetics
FLGT
|
0.476 | $ 18.94 | 2.38 % | $ 583 M | ||
|
Castle Biosciences
CSTL
|
1 | $ 21.24 | 0.76 % | $ 616 M | ||
|
Aspira Women's Health
AWH
|
0.434 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.181 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
0.67 | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
1.1 | $ 148.0 | -2.52 % | $ 11.6 B | ||
|
Illumina
ILMN
|
3.8 | $ 162.41 | 1.48 % | $ 25.2 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
1.97 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-135 | $ 130.19 | 0.05 % | $ 16.3 B | ||
|
CareDx, Inc
CDNA
|
3.28 | $ 23.27 | 2.29 % | $ 1.24 B | ||
|
Chembio Diagnostics
CEMI
|
0.707 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-2.99 | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
0.328 | $ 1.76 | 1.32 % | $ 7.79 M | ||
|
HTG Molecular Diagnostics
HTGM
|
0.554 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
0.0622 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.46 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
8.08 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
0.736 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
0.742 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
4.7 | $ 102.03 | 2.05 % | $ 6.89 B | ||
|
Charles River Laboratories International
CRL
|
2.4 | $ 188.39 | -0.84 % | $ 9.34 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.32 | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
93.1 | $ 1.37 | - | $ 411 M | ||
|
Medpace Holdings
MEDP
|
28.2 | $ 470.6 | 0.82 % | $ 13.6 B | ||
|
Exact Sciences Corporation
EXAS
|
8.12 | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
-1.2 K | $ 1 131.82 | -2.68 % | $ 23.3 B | ||
|
NeoGenomics
NEO
|
1.77 | $ 11.61 | 1.49 % | $ 1.49 B | ||
|
Myriad Genetics
MYGN
|
1.11 | $ 4.61 | 1.43 % | $ 427 M | ||
|
National Research Corporation
NRC
|
22.5 | $ 20.86 | 5.59 % | $ 467 M | ||
|
Natera
NTRA
|
17.8 | $ 216.94 | -2.64 % | $ 29.7 B | ||
|
Personalis
PSNL
|
1.65 | $ 9.77 | 0.21 % | $ 872 M | ||
|
Koninklijke Philips N.V.
PHG
|
2.76 | $ 25.79 | -2.68 % | $ 24.5 B | ||
|
Senseonics Holdings
SENS
|
5.74 | $ 7.23 | -2.69 % | $ 302 M | ||
|
QIAGEN N.V.
QGEN
|
1.84 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
4.63 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
1.75 | $ 2.04 | -0.54 % | $ 4.69 M | ||
|
Twist Bioscience Corporation
TWST
|
3.31 | $ 67.6 | -3.51 % | $ 4.04 B | ||
|
Laboratory Corporation of America Holdings
LH
|
2.77 | $ 270.94 | -0.1 % | $ 22.5 B | ||
|
Thermo Fisher Scientific
TMO
|
1.78 | $ 482.65 | -2.36 % | $ 182 B | ||
|
Trinity Biotech plc
TRIB
|
-5.51 | $ 0.68 | 2.35 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
0.368 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
0.492 | $ 9.16 | -1.35 % | $ 1.99 B | ||
|
Invitae Corporation
NVTA
|
5.02 | - | - | $ 21.2 M |